Family Heart Foundation Study Shows Machine Learning Model Can Help Identify ASCVD Patients at Higher Risk of Elevated Lp(a) The Family Heart Foundation, a leading research, education and advocacy organization…
NImmune Biopharma to Present Clinical and Preclinical Data on NIM-1324 at ACG 2026, Highlighting LANCL2 Potential in Difficult-to-Treat IBD NImmune Biopharma, a private, late-stage precision inflammation and immunology (I&I) biopharmaceutical…
Quanterix Appoints Dr. Yuri Fesko as Chief Medical Officer to Advance Diagnostics Strategy Quanterix Corporation, a global leader in precision biomarker science, has announced the appointment of physician executive Dr.…
Bristol Myers Squibb Reports Positive Phase 2 QUINTESSENTIAL Results for Arlo-Cel in Heavily Pretreated Multiple Myeloma Bristol Myers Squibb (NYSE: BMY) announced positive Phase 2 results from the registrational QUINTESSENTIAL…
IMDELLTRA® Plus IMFINZI® Shows Landmark Overall Survival Benefit in First-Line Extensive-Stage Small Cell Lung Cancer Amgen (NASDAQ: AMGN) announced landmark results from the Phase 3 DeLLphi-305 study, reporting that the…
Novartis Reports HARBOR Phase 3 Study of Del-Desiran in Myotonic Dystrophy Type 1 Misses Primary Endpoint Novartis announced that the global Phase 3 HARBOR study evaluating del-desiran in people living…
Roche Receives FDA Priority Review for Enspryng in MOGAD Following Positive Phase 3 Results Roche announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to a…
Johnson & Johnson to Present 24 Neuropsychiatry Data Sets at Psych Congress 2026 Johnson & Johnson (NYSE: JNJ) will present 24 abstracts featuring clinical trial data and real-world evidence from…
Novo Nordisk Reports Positive Phase 3 STEP Young Results for Semaglutide in Children With Obesity Novo Nordisk has announced the first results from the STEP Young Phase 3 trial evaluating…
Scholar Rock Wins FDA Approval for ISEMBYLD, First Muscle-Targeted Treatment for Spinal Muscular Atrophy Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company focused on developing therapies for rare, severe and…
Strata Mental Health Solutions Awarded Compass Pathways Grant to Develop U.S. Provider Training for COMP360 Strata Mental Health Solutions, an expert-led training and implementation partner focused on preparing clinical networks…
MEDIPAL and JCR Pharmaceuticals Dose First Patient in Global Phase I/II Trial of JR-446 for MPS IIIB MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. (TSE: 4552) announced that the…